Effects of a Supplement on Acute Respiratory Infections
Effects of a Dietary Supplement on the Incidence of Acute Respiratory Infections in Susceptible Adults
Sponsor: Omnilife Manufactura, SA de CV
Listed as NCT02210156, this NA trial focuses on Respiratory Tract Infection and remains completed. Sponsored by Omnilife Manufactura, SA de CV, it has been updated 5 times since 2012, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Omnilife Manufactura, SA de CV
- University of Guadalajara
For direct contact, visit the study record on ClinicalTrials.gov .